What’s New In Ulcerative Colitis?

S

Mirikizumab Achieved Comprehensive Disease Control in Patients with Ulcerative Colitis from Phase 3 LUCENT-1 and LUCENT-2 Trials

By Stefan Schreiber 2 Videos
615 views
December 1, 2023
Comments 0
Login to view comments. Click here to Login
17:18

Medical Therapy in IBD: Past, Present, and Future

David Choi

672 views
11:28

Bowel Urgency: Important but Neglected in Ulcerative Colitis

Subrata Ghosh

334 views
14:53

IL12/23 and IL23 Selective Inhibition in Inflammatory Bowel Disease

Gil Melmed

609 views
18:03

Efficacy and Safety of Mirikizumab as Maintenance Therapy in Patient…

DDW 2022 Conference Coverage

M. Dubinsky

431 views
28:07

Guidelines for Ulcerative Colitis Diagnosis and Management

UChicago Medicine

D. T. Rubin

3.4K views
21:33

Surgery for Ulcerative Colitis: Current Techniques

Columbia University

A. D'Hoore

301 views